Executive Development Programme in Computational Drug Discovery Methods

This course is tailored for senior executives and managers in pharmaceutical and biotech industries seeking to understand and leverage computational drug discovery methods. Participants will gain insights into the latest technologies, including AI and machine learning, and learn how to integrate these tools into their strategic planning to accelerate drug development and enhance R&D efficiency.

Attendees will acquire practical knowledge on evaluating computational models, understanding their applications in drug discovery, and making informed decisions that can lead to faster and more cost-effective drug development processes.

1. 1. Introduction to Computational Drug Discovery: Learners will be introduced to the fundamentals of computational drug discovery, including the role of computational methods in drug development and basic principles of computational chemistry. They will gain foundational knowledge in molecular modeling and the use of software tools for computational analysis.
2. 2. Molecular Modeling Techniques: This module covers various molecular modeling techniques such as molecular mechanics, molecular dynamics, and quantum mechanics calculations. Learners will understand how to build, optimize, and analyze molecular structures using computational tools.
3. 3. Virtual Screening Methods: Learners will study virtual screening methods used to identify potential drug candidates from large compound libraries. They will learn about receptor-ligand interactions, scoring functions, and the practical application of high-throughput screening in drug development.
4. 4. Structure-Based Drug Design: This module focuses on structure-based drug design techniques, including protein-ligand docking and computational prediction of binding affinities. Learners will gain hands-on experience in designing and optimizing small molecules for drug-like properties.
5. 5. Machine Learning in Drug Discovery: Learners will explore the application of machine learning algorithms in drug discovery, including supervised and unsupervised learning techniques. They will learn to develop predictive models for various aspects of drug development using large datasets.
6. 6. High-Performance Computing for Drug Discovery: This module covers the use of high-performance computing resources and cloud computing services for efficient drug discovery workflows. Learners will learn to optimize computational tasks and manage large-scale data processing.
7. 7. Drug Absorption, Distribution, Metabolism, and Excretion (ADME): Learners will study the computational methods used to predict ADME properties of drug candidates. They will learn to use in silico tools for pharmacokinetic and toxicological assessments.
8. 8. Lead Optimization and Molecular Optimization: This module focuses on the use of computational methods to optimize lead compounds, including quantitative structure-activity relationships (QSAR) and pharmacophore modeling. Learners will gain practical skills in improving pharmacological properties of drug candidates.
9. 9. Integrative Approaches in Drug Discovery: Learners will explore integrative approaches that combine multiple computational techniques to enhance drug discovery efforts. They will learn to apply a comprehensive strategy for drug target identification and validation.
10. 10. Regulatory and Ethical Considerations in Computational Drug Discovery: This module covers the regulatory and ethical aspects of computational drug discovery, including data privacy, intellectual property, and the responsible use of computational methods in drug development.